Rachel Yesharim

Rachel joined AposHealth in 2021 to build and lead the company’s new AposIQ business unit, that will combine innovative technology and data science with Apos’s comprehensive experience in gait modification to determine the optimal way to adjust patients’ gaits over time.

Prior to AposHealth®, Rachel was Vice President of product at Medial EarlySign – a pioneering clinical AI company – were she defined the company’s roadmap and took its products from concept to reality. Rachel began her career at Intel® and along 10 years held various leading roles, including product management at Intel’s Advanced Analytics unit. Rachel holds a BSc in Computer Science with specialization in Bioinformatics from Ben-Gurion University.